Umbilical Cord Blood Mononuclear Cell

BIOLOGICAL3 trials

Sponsors

China Spinal Cord Injury Network, StemCyte, Inc.

Conditions

Spinal Cord Injuries

Phase 1

Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord

CompletedNCT01046786

China Spinal Cord Injury NetworkSpinal Cord Injuries

Start: 2010-01-31End: 2013-12-31Updated: 2014-01-28

Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury

CompletedNCT01354483

China Spinal Cord Injury NetworkSpinal Cord Injuries

Start: 2011-09-30End: 2013-12-31Updated: 2014-08-21

Phase 2

Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor Training

TerminatedNCT03979742

StemCyte, Inc.Spinal Cord Injuries

Start: 2022-02-22End: 2024-12-30Updated: 2025-02-28